In the diagnosis of Alzheimer’s disease and the search for effective treatments, tau tangles in the brain have joined amyloid build-up as markers of the disease and potential therapy targets. In the December issue of The Journal of Nuclear Medicine, the featured article of the month reports on the identification of a promising second-generation positron emission tomography (PET) tracer for imaging and measuring tau pathology. {read more here}